Kerecis Completes...

Symposium on Advanced Wound Care, Denver, Colorado, May 3, 2013— Kerecis today announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen Omega3...

Kerecis Completes...

Reykjavik / Isafjordur, Iceland, April 26, 2013 – Kerecis Limited, the emerging tissue-regeneration company, today announced that it has secured US$ 1 million in series A2 funding. The financing, a...

Kerecis Announces a...

Dubai, United Arab Emirates, January 31, 2013 — At the Arab Health Conference today, Kerecis announced the signing of a distribution agreement with Medline Industries, Inc. based in Mundelein,...

Follow-Up Study...

Reykjavik/Isafjordur, Iceland, May 18, 2012 — Kerecis, the emerging tissue-regeneration company, has successfully completed a 37-patient follow-up study of its MariGen Wound treatment product for...

Clinical Trial...

Reykjavik/Isafjordur, Iceland, October 6, 2011 — Kerecis, the emerging tissue-regeneration company, has successfully completed the first human clinical trial of its MariGen Lipid Collagen Matrix....

Minister of...

Reykjavik/Isafjordur, Iceland, September 26, 2011 — Iceland’s Minister of Industry Katrin Juliusdottir today inaugurated the Kerecis Medical Device manufacturing facility in Isafjordur,...

Minister of...

Reykjavik/Isafjordur, Iceland, September 26, 2011 — Iceland’s Minister of Industry Katrin Juliusdottir today inaugurated the Kerecis Medical Device manufacturing facility in Isafjordur,...

Kerecis to Present...

Reykjavik/Isafjordur, Iceland, June 20, 2011 — Kerecis Limited, the emerging tissue-regeneration company, today announced that its Chairman G. Fertram Sigurjonsson will make a presentation at...

Kerecis Completes...

Reykjavik/Isafjordur, Iceland, May 24, 2011 – Kerecis Limited, the emerging tissue-regeneration company, has secured US$ 1 million in interim financing. The US$ 1 million financing is a mixture...

Kerecis Limited...

Reykjavik/Isafjordur, Iceland, March 24, 2011 — Kerecis Limited, the emerging tissue-regeneration company, has received the International Organization for Standardization (ISO) 13485:2003...